Non-Invasive Prenatal Tests (NIPT) are globally recognised as the leading methodology for evaluating potential chromosomal conditions during pregnancy.
We can offer a varying range of NIPT testing options for your patients to ensure their needs and requirements are met. All reporting is completed through the TrackR system to ensure a complete audit trail. Due to the nature and sensitivity of these tests, turnaround time is a critical focus for the entire HTS Labs team.
At HTS Labs, we’ve formed a partnership with a specialised NIPT testing laboratories in the EU and the US to ensure the highest caliber of service for our clients.
Our Test Offering
Harmony
The World’s Most Recognisable NIPT Test
The Harmony Test screens for the detection of:
- Trisomy 21 (Down syndrome)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
- Sex Chromosomal Disorders
- Fetal Sex Determination (optional)
Panorama
The only SNP-based NIPT delivers more insights with high accuracy
- Trisomy 21 (Down syndrome)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
- Triploidy
- Monosomy X (Turner syndrome)
- Sex Chromosomal trisomies
- Fetal Sex Determination (optional)
- 22q11.2 deletion syndrome (additional)
- Four microdeletions panel (additional)
Rhesus
Determination of the fetal Rhesus factor from maternal blood
You may already know your blood type, for example if you are a blood donor. Your blood type is also determined as part of maternity care at the beginning of your pregnancy to determine if you have the blood group factor RhD-negative (“Rhesus-negative”). About 17% of all women are RhD- negative.